
In this lecture from This is Why, Dr. Busti will learn about the application of DPP-4 inhibitors in the management of type 2 diabetes mellitus (T2DM). The DPP-4 inhibitors (e.g., sitagliptin, linagliptin, saxagliptin) have an impact of incretins (GIP, GLP-1) which have continued to evolve in other treatment options.
You’ll learn how to:
- Mechanism of action: DPP-4 inhibition and impact on incretins (GLP-1/GIP)
- Key drugs: Sitagliptin, linagliptin, saxagliptin
- Clinical role: where DPP-4 inhibitors fit in type 2 diabetes treatment, including add-on therapy
- Adverse effects & safety pearls: the side effects and warnings you need to know for exams and practice
The goal = make medical education easy and clinically relevant.
Chapter Table of Contents
00:00 Introduction: DPP-4 Inhibitors for Type 2 Diabetes (Pharmacology Overview)
01:39 DPP-4 Inhibitor Drugs List (Sitagliptin, Saxagliptin, Linagliptin, Alogliptin)
02:34 Indications & Clinical Use: Adjunct to Diet + Exercise (T2DM)
02:59 Why Use DPP-4 Inhibitors? Benefits (Weight Neutral, Low Hypoglycemia Risk)
04:04 Mechanism of Action: DPP-4 Enzyme + Incretins (GLP-1 & GIP Explained)
05:16 Effects on Glucose Control: Insulin, Glucagon, Hepatic Glucose Output
06:07 Pharmacokinetics & Drug Interactions (CYP3A4/P-gp: Linagliptin & Saxagliptin)
07:35 Where DPP-4 Inhibitors Fit in Guidelines (2nd Line, Metformin Add-On)
09:14 Cardiovascular & Heart Failure Concerns (Alogliptin/Saxagliptin Warnings)
10:06 Best Candidates: Postprandial Glucose Control + Oral Therapy Preference
15:02 Comorbidities & When to Avoid (Renal Impairment, HF, Pancreatitis Risk)
17:18 Key Adverse Effects & Monitoring (Arthralgia, Pancreatitis, Skin Reactions, LFTs)
If this helped you, please like, subscribe to our YouTube Channel, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.
Don’t forget to turn on notifications on YouTube so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!
#dpp4inhibitors #type2diabetes #sitagliptin #diabetespharmacology #busti
Disclaimer:
This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Antidiabetic Agents Lecture Tables
Antidiabetic Agents Lecture Tables